sulpiride has been researched along with Anankastic Personality in 16 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the study was to investigate the prevalence rates of obsessive-compulsive disorder (OCD) and hypochondriasis in schizophrenic patients treated with atypical antipsychotics (AAPs) and to investigate the different comorbidity rates of OCD and hypochondriasis between clozapine-treated patients and patients treated with other AAPs." | 7.80 | Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics. ( Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L, 2014) |
| "A 14-year-old boy with obsessive-compulsive disorder (OCD) developed, under fluvoxamine treatment, acute symptoms of Tourette's syndrome (TS) with aggravation of the OCD." | 7.69 | Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder. ( Fennig, S; Fennig, SN; Pato, M; Weitzman, A, 1994) |
| "Amisulpiride 200 mg/day was added to ongoing SRI treatment and titrated up to 600 mg/day in flexible doses." | 6.71 | Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial. ( Metin, O; Tot, S; Yazici, AE; Yazici, K, 2003) |
| "The aim of the study was to investigate the prevalence rates of obsessive-compulsive disorder (OCD) and hypochondriasis in schizophrenic patients treated with atypical antipsychotics (AAPs) and to investigate the different comorbidity rates of OCD and hypochondriasis between clozapine-treated patients and patients treated with other AAPs." | 3.80 | Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics. ( Cantisani, A; Ferrari, G; Grassi, G; Pallanti, S; Poli, L; Righi, L, 2014) |
| "We stratified 70 patients with schizophrenia according to their mode of antipsychotic treatment: clozapine and olanzapine (group I) compared with aripiprazole and amisulpride (group II)." | 3.77 | Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia. ( Englisch, S; Esslinger, C; Meyer-Lindenberg, A; Rausch, F; Schirmbeck, F; Zink, M, 2011) |
| "A 14-year-old boy with obsessive-compulsive disorder (OCD) developed, under fluvoxamine treatment, acute symptoms of Tourette's syndrome (TS) with aggravation of the OCD." | 3.69 | Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder. ( Fennig, S; Fennig, SN; Pato, M; Weitzman, A, 1994) |
| "Amisulpiride 200 mg/day was added to ongoing SRI treatment and titrated up to 600 mg/day in flexible doses." | 2.71 | Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial. ( Metin, O; Tot, S; Yazici, AE; Yazici, K, 2003) |
| "Patients with Tourette's syndrome often develop multiple psychopathological symptoms beyond the basic symptoms (motor and vocal tics)." | 1.31 | [Disguised Tourette's syndrome. A contribution to the differential diagnosis on phobia and fear]. ( Barnett, W; Bednarz, K; Haisch, S, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 7 (43.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naguy, A | 1 |
| Grassi, G | 1 |
| Poli, L | 1 |
| Cantisani, A | 1 |
| Righi, L | 1 |
| Ferrari, G | 1 |
| Pallanti, S | 1 |
| Mendhekar, DN | 1 |
| Schirmbeck, F | 1 |
| Esslinger, C | 1 |
| Rausch, F | 1 |
| Englisch, S | 1 |
| Meyer-Lindenberg, A | 1 |
| Zink, M | 1 |
| Ersche, KD | 2 |
| Cumming, P | 1 |
| Craig, KJ | 2 |
| Müller, U | 2 |
| Fineberg, NA | 2 |
| Bullmore, ET | 2 |
| Robbins, TW | 2 |
| Roiser, JP | 1 |
| Abbott, S | 1 |
| Suckling, J | 1 |
| Ooi, C | 1 |
| Shabbir, SS | 1 |
| Clark, L | 1 |
| Sahakian, BJ | 1 |
| Merlo-Pich, EV | 1 |
| Rickards, H | 1 |
| Cavanna, AE | 1 |
| Worrall, R | 1 |
| Bednarz, K | 1 |
| Haisch, S | 1 |
| Barnett, W | 1 |
| Metin, O | 1 |
| Yazici, K | 1 |
| Tot, S | 1 |
| Yazici, AE | 1 |
| Poyurovsky, M | 1 |
| Weizman, R | 1 |
| Weizman, A | 1 |
| Koran, L | 1 |
| Kim, SW | 1 |
| Shin, IS | 1 |
| Kim, JM | 1 |
| Yang, SJ | 1 |
| Hwang, MY | 1 |
| Yoon, JS | 1 |
| Fennig, S | 1 |
| Fennig, SN | 1 |
| Pato, M | 1 |
| Weitzman, A | 1 |
| George, MS | 1 |
| Trimble, MR | 1 |
| Sevincok, L | 1 |
| Uslu, A | 1 |
| Kaynak, H | 1 |
| Dereboy, F | 1 |
| Baving, L | 1 |
| Schmidt, MH | 1 |
| Stárková, L | 1 |
| Wiedermann, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Augment in Treatment-resistent Obsessive-compulsive Disorder: an Open-label Trial[NCT00590642] | 30 participants (Anticipated) | Observational | 2006-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for sulpiride and Anankastic Personality
| Article | Year |
|---|---|
Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D(2/3) receptor agonist.
Topics: Adult; Amisulpride; Amphetamine-Related Disorders; Benzothiazoles; Brain Mapping; Cocaine-Related Di | 2011 |
Amisulpiride augmentation in treatment resistant obsessive-compulsive disorder: an open trial.
Topics: Adult; Aged; Amisulpride; Antidepressive Agents; Antipsychotic Agents; Drug Resistance; Drug Therapy | 2003 |
Dystonic reaction associated with fluvoxamine.
Topics: Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Dystonia; F | 1993 |
13 other studies available for sulpiride and Anankastic Personality
| Article | Year |
|---|---|
An Adult With Obsessive-Compulsive-Related Disorders and Tics Post-Carbon Monoxide Poisoning Who Responded Ultimately to Electroconvulsive Therapy.
Topics: Adult; Antipsychotic Agents; Carbon Monoxide Poisoning; Combined Modality Therapy; Electroconvulsive | 2019 |
Hypochondriasis and obsessive-compulsive disorder in schizophrenic patients treated with clozapine vs other atypical antipsychotics.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Fem | 2014 |
Hyperpigmentation with amisulpride.
Topics: Adult; Amisulpride; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Female; Fluvox | 2009 |
Antiserotonergic antipsychotics are associated with obsessive-compulsive symptoms in schizophrenia.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Comorbidity; Fem | 2011 |
Amisulpride-induced acute akathisia in OCD: an example of dysfunctional dopamine-serotonin interactions?
Topics: Adult; Akathisia, Drug-Induced; Amisulpride; Dopamine; Female; Humans; Male; Obsessive-Compulsive Di | 2012 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride | 2012 |
[Disguised Tourette's syndrome. A contribution to the differential diagnosis on phobia and fear].
Topics: Adult; Anxiety Disorders; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Combined Modality | 2002 |
Memantine for treatment-resistant OCD.
Topics: Adult; Clomipramine; Dopamine Antagonists; Drug Therapy, Combination; Excitatory Amino Acid Antagoni | 2005 |
Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
Topics: Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Comorbidity; Dopamine Antagonists; Dose-Resp | 2008 |
Emergence of symptoms of Tourette's syndrome during fluvoxamine treatment of obsessive-compulsive disorder.
Topics: Adolescent; Arousal; Drug Therapy, Combination; Fluvoxamine; Humans; Loxapine; Male; Neurologic Exam | 1994 |
Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology.
Topics: Antidepressive Agents, Second-Generation; Female; Fluvoxamine; Humans; Middle Aged; Obsessive-Compul | 2000 |
[Obsessive-compulsive disorder, frontostriatal system and the effect of the serotonergic system].
Topics: Adolescent; Behavior Therapy; Child; Clomipramine; Combined Modality Therapy; Female; Fluvoxamine; H | 2000 |
Our experience with incisive neuroleptic drugs in child psychiatry.
Topics: Antipsychotic Agents; Autistic Disorder; Child; Haloperidol; Humans; Mental Disorders; Obsessive-Com | 1991 |